Paulo Sergio Fonseca De Sousa
Overview
Explore the profile of Paulo Sergio Fonseca De Sousa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lago B, Portilho M, Mello V, De Sousa P, Angelice G, Marques B, et al.
Sci Rep
. 2024 May;
14(1):10742.
PMID: 38730249
The selection pressure imposed by the host immune system impacts on hepatitis B virus (HBV) variability. This study evaluates HBV genetic diversity, nucleos(t)ide analogs resistance and HBsAg escape mutations in...
2.
Vasconcelos M, Sanchez-Arcila J, Peres L, De Sousa P, Castro-Alves J, Albuquerque H, et al.
BMC Infect Dis
. 2024 Jan;
24(1):15.
PMID: 38166687
Background: Viral hepatitis is a significant health concern among indigenous population in the Americas. In Brazil, reports find high endemicity of HBV and HDV infections has been reported in several...
3.
Vasconcelos M, Sanchez-Arcila J, Peres L, De Sousa P, Dos Santos Alvarenga M, Castro-Alves J, et al.
J Infect Public Health
. 2023 Feb;
16(4):603-610.
PMID: 36842196
The Brazilian Amazon rainforest region has a significant prevalence of malarial and intestinal parasitic infections in indigenous populations, accounting for a disproportionate burden. Thus, a cross-sectional study was conducted to...
4.
Hoogeveen R, Dijkstra S, Bartsch L, Drescher H, Aneja J, Robidoux M, et al.
J Hepatol
. 2022 Jun;
77(5):1276-1286.
PMID: 35716846
Background & Aims: With or without antiviral treatment, few individuals achieve sustained functional cure of chronic hepatitis B virus (HBV) infection. A better definition of what mediates functional cure is...
5.
Villar L, Fraga K, Mendonca A, Miguel J, Silva E, Barbosa J, et al.
Braz J Infect Dis
. 2022 Jun;
26(3):102371.
PMID: 35661641
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) are more vulnerable to blood-borne viral infections due to frequent invasive procedures. Hepatitis B virus (HBV) infection in this cohort of patients...
6.
Peliganga L, Mello V, De Sousa P, Horta M, Soares A, Nunes J, et al.
Pathogens
. 2021 Dec;
10(12).
PMID: 34959588
Transfusion transmissible infections (TTIs), caused by hepatitis B virus (HBV), human immunode-ficiency virus (HIV), hepatitis C virus (HCV), and syphilis, have a high global impact, especially in sub-Saharan Africa. We...
7.
Chen D, Wolski D, Aneja J, Matsubara L, Robilotti B, Hauck G, et al.
J Clin Invest
. 2020 Jan;
130(2):768-773.
PMID: 31904582
CD4+ T cell failure is a hallmark of chronic hepatitis C virus (HCV) infection. However, the mechanisms underlying the impairment and loss of virus-specific CD4+ T cells in persisting HCV...
8.
Tonnerre P, Melgaco J, Torres-Cornejo A, Pinto M, Yue C, Blumel J, et al.
Nat Microbiol
. 2019 Dec;
5(1):76-83.
PMID: 31792427
Zika virus (ZIKV) is a flavivirus that is closely related to other human pathogens, such as dengue virus (DENV). Primary transmission usually involves Aedes aegypti, which has expanded its distribution...
9.
Costa V, Delvaux N, Brandao-Mello C, Nunes E, De Sousa P, de Souza Rodrigues L, et al.
Clin Res Hepatol Gastroenterol
. 2019 Mar;
43(6):700-706.
PMID: 30880098
Background And Aims: Treatment for hepatitis C has evolved significantly with the licensing of direct-acting antiviral drugs (DAAs). However, one of the limiting factors of the effectiveness of antiviral therapy...
10.
Almeida R, Mello F, Menegoy I, Espirito Santo M, Ginuino C, De Sousa P, et al.
Mem Inst Oswaldo Cruz
. 2017 Jun;
112(7):485-491.
PMID: 28591309
Background: Many studies have identified mutations in the hepatitis B surface antigen (HBsAg) as important factors limiting the ability of commercial serological assays to detect this viral antigen. However, an...